Bristol Myers Squibb
- A10 - Antidiabéticos
- ONGLYZA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ELIQUIS film-coated tablet 2.5 mg
- ELIQUIS film-coated tablet 5 mg
- J02 - Antimicóticos de uso sistémico
- FUNGIZONE powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- DAKLINZA tablet 60 mg
- SUNVEPRA capsule, soft 100 mg
- L01 - Antineoplásicos
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- TAXOL concentrate for solution for infusion 100 mg/16.7 ml
- TAXOL concentrate for solution for infusion 30 mg/5 ml
- YERVOY concentrate for solution for infusion 200 mg/40 ml
- YERVOY concentrate for solution for infusion 50 mg/10 ml
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED PEN solution for injection 125 mg
- N02 - Analgésicos
- PERFALGAN solution for infusion 1 g/100 ml
- N05 - Psicolépticos
- ABILIFY oral solution 1 mg/ml
- ABILIFY tablet 10 mg
- ABILIFY tablet 15 mg
- ABILIFY tablet 30 mg